In March 2025, the company declared new ideas to get a direct-to-client offering of its Wegovy weight loss drug. The company established a new pharmacy, named NovoCare, which might charge prospects $499 each month for access to the drug, fewer than half the cost of the drug by way of other pharmaceutical distribution networks.[53]Include these bits